ESG resolution round-up: Ambiguity around new Swiss law prompts confusion ahead of Novartis AGM

Novartis to put sustainability report up for advisory vote; Exxon lawsuit ‘a governance issue’ but investors remain quiet; Mirova makes third-party assurance demands.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.